Photo of Kimberly Gillespie

Kimberly Gillespie is a practical, results-oriented healthcare attorney with experience advising academic medical centers and health systems across the country. She is dedicated to partnering with her clients to fully understand their business goals and objectives and provide solutions to complex regulatory and operational issues.

Q: What issues should my business begin to address so that when COVID-19 vaccines are ready for distribution, we will be ready?

A: On a nearly daily basis, Americans hear promising news about vaccine developments that will help protect us from COVID-19. As the reality of a safe, effective, and accessible vaccine draws closer, industries and businesses across the country have started developing their own COVID-19 vaccine strategies. These entities have quickly discovered that any vaccine policy implemented will raise complicated questions not previously faced. While historic annual influenza vaccine strategies are informative, COVID-19 vaccine issues bring new challenges because of the sheer magnitude of the pandemic and the unique issues surrounding the pace of development and distribution. Businesses should proactively address these issues now so when the COVID-19 vaccines are ready for distribution, they will be too.Continue Reading When the COVID-19 Vaccine Arrives, Will Your Business Be Ready?